Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15855189 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Phase I, Arteriocyte Magellan MAR01 Therapy - Compartment Syndrome and Battlefield Trauma
Condition: Compartment Syndrome
Intervention: Device: Magellan®

Indicates status has not been verified in more than two years